Article
New York-Treatment with oral desmopressin significantly reduces the rateof nocturnal voiding episodes in men with nocturia, results of a placebo-controlledtrial suggest. One-third of men treated with desmopressin (DDAVP) had at least a 50%reduction in nighttime voiding compared with 3% of placebo-treated patientsafter 3 weeks.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.